microRNA in the development of diabetic complications. (Q30353835)

20 June 2017

microRNA in the development of diabetic complications. (English)

1 reference

20 June 2017

1 reference

Aaron D McClelland

1

1 reference

PubMed ID

24059587

20 June 2017

Phillip Kantharidis

series ordinal

2

1 reference

PubMed ID

24059587

20 June 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

20 June 2017

1 reference

20 June 2017

126

1 reference

20 June 2017

95-110

1 reference

20 June 2017

2

1 reference

The global obesity pandemic: shaped by global drivers and local environments

20 June 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Connecting type 1 and type 2 diabetes through innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Inflammatory mechanisms of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs in disease and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Small non-coding RNAs in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Mutations that lead to reiterations in the cell lineages of C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Identification of novel genes coding for small expressed RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Tissue-dependent paired expression of miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Characterizing the role of miRNAs within gene regulatory networks using integrative genomics techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Diabetes complications: the microRNA perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

The role of inflammatory cytokines in diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Atherosclerosis: current pathogenesis and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Insulin secretion in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Mechanisms of obesity-associated insulin resistance: many choices on the menu

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Natural history of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-181a is an intrinsic modulator of T cell sensitivity and selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-375 maintains normal pancreatic alpha- and beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Adipose tissue inflammation and liver pathology in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Alternative macrophage activation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-125b potentiates macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Inflammation in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-21 and miR-214 are consistently modulated during renal injury in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Macrophages and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Pathogenetic mechanisms of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-192 mediates TGF-beta/Smad3-driven renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Smad3-mediated upregulation of miR-21 promotes renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Identification of a microRNA signature of renal ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs and the kidney: coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Roles of microRNAs in atherosclerosis and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MiR-34, SIRT1 and p53: the feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Circulating microRNAs in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

The magic and mystery of microRNA-27 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Diabetic cardiomyopathy: pathophysiology and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Macrophages modulate cardiac function in lipotoxic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-21 in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Role of microRNAs in diabetes and its cardiovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

microRNAs in hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Urinary microRNA profiling in the nephropathy of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Microparticles: major transport vehicles for distinct microRNAs in circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Experimental strategies for microRNA target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

A direct comparison of anti-microRNA oligonucleotide potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

A cardiac microRNA governs systemic energy homeostasis by regulation of MED13

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

The therapeutic potential of microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

21 January 2018

MicroRNA therapeutics.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA sponges: progress and possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130079

21 January 2018

Identifiers

DOI

10.1042/CS20130079

1 reference

20 June 2017

1 reference

PubMed ID

24059587